We recently published a list of the 11 Best Young Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GE HealthCare Technologies Inc.

The company also strengthened its position by acquiring the remaining 50% stake in Nihon Medi-Physics/NMP in Q1. NMP is a radiopharmaceutical company in Japan that is expected to contribute ~$150 ...

In March, GE HealthCare acquired the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP) from Sumitomo Chemical, giving it full ownership.

In March, GE HealthCare acquired the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP) from Sumitomo Chemical, giving it full ownership.

Kevin O'Neill, President & CEO of GE HealthCare's Pharmaceutical Diagnostics (PDx) segment, who will also become President of NMP, said:“We are delighted to welcome Nihon Medi-Physics to GE ...

GE HealthCare Technologies Inc, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data ...

“Since its establishment in 1973, Nihon Medi-Physics has made a significant contribution to our business performance, but there are few synergies with us, so we decided to target the company for ...

GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As part of GE HealthCare, NMP, already a leading ...

GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), from Sumitomo Chemical ...

Cardiac CT angiography, or CCTA, is used to help diagnose coronary artery disease, and can be employed as a first-line tool for patients suffering from chest pain. GE HealthCare said the ...